近似商標分開轉讓合同的效力及法律後果

来源 :中国专利与商标 | 被引量 : 0次 | 上传用户:yjcog
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
2013年《商標法》在2001年《商標法》關於商標轉讓規定的基礎上增加了兩款,即第四十二條第二款和第三款,規定近似商標應當一並轉讓,從立法層面對商標轉讓進行了限制。該限制的立足點是爲了避免消費者產生混淆,具有明顯保護公共利益的傾向。與之相對應,《商標法實施條例》第三十一條第二款對近似商標未一並轉讓的後果做了規定,用詞分别是“限期改正”和“視爲放棄申請”;在第四十七條關於指定中國領土延伸申請轉讓條款中,則直接用了“轉讓無效”一詞。那麼,近似商標分開轉讓後的“限期改正”和“視爲放棄申請”究竟是一種 The Trademark Law of 2013 added two paragraphs on the basis of the provisions of the Trademark Law of 2001 on the transfer of trademarks, namely, Article 42, paragraphs 2 and 3, stipulating that similar marks should be transferred together from the legislative level In the face of trademark transfer restrictions. The foothold of this restriction is to avoid confusion among consumers and to have a clear propensity to protect the public interest. Correspondingly, the second paragraph of Article 31 of the “Regulations for the Implementation of the Trademark Law” stipulates the consequences of the non-simultaneous transfer of similar marks. The wordings are respectively “deadline correction” and “deemed as waiver of application” “In the forty-seventh article on the extension of the application of the designated territory of China transfer of terms, the direct use of the” invalid transfer “. Well, after the approximate trademark transfer separately ”deadline correction “ and ”as a waiver of application " is exactly what kind of
其他文献
小猪过生日
目的 了解高龄白内障晶状体超声乳化术后泪膜的变化情况.方法 选择高龄(>80岁)晶状体超声乳化手术23例(28眼)作为高龄组,另随机抽取老年性白内障30例(39眼)作为对照组.分别于术前、术后1、7、30、90及120 d进行症状、角膜荧光素染色(FL)、泪膜破裂时间(BUT)、基础泪液分泌试验(SIt)调查.结果 与术前相比,两组术后120 d内主诉眼部不适症状者明显增多;两组术后1周内FL增多